Skip to content

Marcaine Use in Laparoscopic Gynecological Surgery

A Comparative Trial of Marcaine Administration in Laparoscopic Gynecologic Surgery Using Either a Pre- or Post-operative Injection.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01861665
Acronym
Marcaine
Enrollment
27
Registered
2013-05-23
Start date
2010-06-30
Completion date
2017-01-31
Last updated
2018-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative Pain

Brief summary

The purpose of this trial is to compare incisional pain in patients receiving pre-incisional versus post operative Marcaine injection.

Detailed description

Post-operative pain control is a key component of a patient's experience with surgery. In laparoscopic surgery, small (5 to 12mm) incisions are made, usually at the umbilicus and/on at either side of the lower abdomen, to allow insertion of a laparoscopic camera (scope) and various laparoscopic instruments. The advantages for the patient of this approach compared to conventional open surgery include faster recovery with a significantly shorter hospital stay, less pain and less requirements for pain medication with a better cosmetic outcome. In many cases, the patient will go home within 24 hours of surgery. Many laparoscopic surgeons administer local anesthesia at the incision sites to assist in post-operative pain control. The best method for administration of the local anesthetic for optimal pain relief remains unclear. Some research has demonstrated that perhaps preemptive administration of local anesthetic improves post-operative pain control although in these studies, differences in patient populations and perception of pain between different patients makes comparison difficult. Optimizing analgesia protocols would benefit patients resulting in better pain relief and less use of narcotic analgesics with their associated side effects.

Interventions

Marcaine 0.25% administered pre-incision.

DRUGMarcaine 0.25%.

Marcaine 0.25% administered post-incision.

Sponsors

Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Patients are acting as their own control receiving Bupivicaine (Marcaine) on both sides. One arm is pre incision the other arm is post incision.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* • Ages 18-50 * BMI 20-35 * Gynecologic ambulatory cases only * Total of 3 incisions, with left and right incisions both being 5mm-10mm in size * Not taking pain medications prior to surgery * Length of surgery up to 3 hours * PACU stay up to 6 hours * Willing and able to sign informed consent

Exclusion criteria

* • Age or BMI out of range * Surgery longer than 3 hours or PACU stay longer than 6 hours * patients with chronic pelvic pain * Oncologic cases * Pregnant patients

Design outcomes

Primary

MeasureTime frameDescription
Wong-Baker Faces Pain Rating ScalePost surgery day 0, post surgery day 1, post surgery day 2Pain level on post op day 1 and 2 study hypothesize will be less if Marcaine is administered pre instead of post incision. The pain scale is a numeric pain rating scale from 0-5, with zero being no pain and 5 being the worst pain imaginable, faces depicting no pain to worst pain.

Countries

United States

Participant flow

Participants by arm

ArmCount
Medication Pre Incision Left Med Post Incision Right
Participants acted as their own control with left side being injected with medication pre incision and right side being injected with medication post incision.
10
Medication Pre Incision Right Med Post Incision Left
Participants acted as their own control with right side being injected with medication pre incision and left side being injected with medication post incision.
17
Total27

Baseline characteristics

CharacteristicMedication Pre Incision Right Med Post Incision LeftTotalMedication Pre Incision Left Med Post Incision Right
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
17 Participants27 Participants10 Participants
Age, Continuous30.92 years
STANDARD_DEVIATION 3.87
32.26 years
STANDARD_DEVIATION 4.83
33.6 years
STANDARD_DEVIATION 5.79
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
17 participants27 participants10 participants
Sex: Female, Male
Female
17 Participants27 Participants10 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 270 / 27
other
Total, other adverse events
0 / 270 / 27
serious
Total, serious adverse events
0 / 270 / 27

Outcome results

Primary

Wong-Baker Faces Pain Rating Scale

Pain level on post op day 1 and 2 study hypothesize will be less if Marcaine is administered pre instead of post incision. The pain scale is a numeric pain rating scale from 0-5, with zero being no pain and 5 being the worst pain imaginable, faces depicting no pain to worst pain.

Time frame: Post surgery day 0, post surgery day 1, post surgery day 2

ArmMeasureGroupValue (MEAN)Dispersion
Marcaine Administered Pre-incisionWong-Baker Faces Pain Rating ScalePost Op day 01.675 units on a scaleStandard Deviation 1.39
Marcaine Administered Pre-incisionWong-Baker Faces Pain Rating ScalePost Op day 12 units on a scaleStandard Deviation 0.97
Marcaine Administered Pre-incisionWong-Baker Faces Pain Rating ScalePost Op day 21 units on a scaleStandard Deviation 1.6
Marcaine Administered Post IncisionWong-Baker Faces Pain Rating ScalePost Op day 01.6 units on a scaleStandard Deviation 1.42
Marcaine Administered Post IncisionWong-Baker Faces Pain Rating ScalePost Op day 11.85 units on a scaleStandard Deviation 1.45
Marcaine Administered Post IncisionWong-Baker Faces Pain Rating ScalePost Op day 20.75 units on a scaleStandard Deviation 0.65
p-value: 0.8379t-test, 2 sided
p-value: 0.7263t-test, 2 sided
p-value: 0.5t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026